PATENT CLAIM ANALYSIS

Application Number: 16087223
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-04
Patent Classification: ["514", "016500"]

Abstract:
Disclosed are CD31 shed  agonists for use in the prevention and/or treatment of reperfusion injury. These CD31 shed  agonists are peptides or peptidomimetics thereof that are able to restore CD31 signaling in cells bearing a truncated form of CD31 called CD31 shed . The CD31 shed  agonists particularly protect from organ damages caused by reperfusion used to treat ischemia.

Claim (Index 20):
The method according to  claim 16 , wherein said peptide is selected in the group consisting of a peptide of sequence SEQ ID NO: 2, a peptide of sequence SEQ ID NO: 3, a peptide of sequence SEQ ID NO: 4, a peptide of sequence SEQ ID NO: 5, a peptide of sequence SEQ ID NO: 6 consisting of D-enantiomer amino acids, a peptide of sequence SEQ ID NO: 7 and a peptide of sequence SEQ ID NO: 8 consisting of D-enantiomer amino acids.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 97.0
- Lexical Diversity: 1.4186
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['14809603', '13001513', '12645991', '11901939', '13782881']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8219436354592929
- 35 USC 102 Novelty (BERT): 0.5232540954177954
- Combined Prediction Score: 0.7920746814551433
- Mean Citation Score: 325.796382
- Max Citation Score: 339.41687
- Similarity Product: 246.12310211572827

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test